PubMed Health⌕ Search

Biomedical subjects

V Trimble

Publications and source records attributed to V Trimble.

6 recordsLinked to original sources
PubMed1997

Origin of the biologically important elements.

The chemical elements most widely distributed in terrestrial living creatures are the ones (apart from inert helium and neon) that are commonest in the Universe--hydrogen, oxygen, carbon, and nitrogen. A chemically different Universe would clearly have different biology, if any. We explore here the nuclear processes in stars, the early Universe, and elsewhere that have produced these common elements, and, while we are at it, also encounter the production of lithium, gold, uranium, and other elements of sociological, if not biological, importance. The relevant processes are, for the most part, well understood. Much less well understood is the overall history of chemical evolution of the Galaxy, from pure hydrogen and helium to the mix of elements we see today. One implication is that we cannot do a very good job of estimating how many stars and which ones might be orbited by habitable planets.

Carbon↗
PubMed1996

Astrophysical symmetries.

Astrophysical objects, ranging from meteorites to the entire universe, can be classified into about a dozen characteristic morphologies, at least as seen by a blurry eye. Some patterns exist over an enormously wide range of distance scales, apparently as a result of similar underlying physics. Bipolar ejection from protostars, binary systems, and active galaxies is perhaps the clearest example. The oral presentation included about 130 astronomical images which cannot be reproduced here.

Journal Article↗
PubMed1992

Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis.

Sulphasalazine extends remissions and lessens disease activity during relapses of ulcerative colitis, but it also causes many adverse side-effects. The adverse reactions are mostly attributable to the sulphapyridine carrier moiety rather than the active principle 5-aminosalicylic acid (5-ASA), so agents to deliver 5-ASA to the colon by other means have been designed. We have compared the efficacy and tolerability of two such agents, olsalazine and mesalazine, in maintenance therapy of ulcerative colitis. 100 patients with ulcerative colitis in remission were recruited at one centre and assigned randomly to treatment with olsalazine (Dipentum; 1.0 g daily) or mesalazine (Asacol, with Eudragit-S coating; 1.2 g daily). Compliance, biochemical and haematological variables, and clinical evidence of disease activity were assessed every 3 months for 12 months by observers unaware of treatment allocation. In intention-to-treat analysis, which included as treatment failures patients withdrawn for protocol violations, adverse reactions, intercurrent illness, or non-compliance as well as those with relapses of ulcerative colitis, the olsalazine group had a significantly lower rate of treatment failure than the mesalazine group (12/49 [24%] vs 23/50 [46%]; p = 0.025). Analysis restricted to 64 patients still in remission at 1 year and 18 with relapses also showed a significant difference in relapse rate (olsalazine 5/42 [12%] vs mesalazine 13/40 [33%]; p = 0.024). Both drugs were well tolerated; only 9 patients reported substantial side-effects. Olsalazine was clearly superior to mesalazine in prevention of relapses in ulcerative colitis, especially in patients with left-sided disease.

Adolescent↗